Tag: Pharmaceutical Benefit Manager (PBM)

Ruling Allows Millions to Join Lawsuit in EpiPen Racketeering Case

US District Judge Daniel Crabtree ruled numerous lawsuits against the marketer and manufacturer of EpiPen may proceed as a nationwide class-action under a federal racketeering statute.
Keller Rohrbach

Have You Paid $100 or More for an EpiPen? Here’s How...

Attorneys are working on a class-action lawsuit to seek justice for the strain rising EpiPen costs have put on people dealing with food allergies.
Heather Bresch Testifying Before House Oversight Committee

Mylan Accused of Secretly Maneuvering to Suppress Evidence in EpiPen Lawsuit

Mylan is accused of foul play in suppression of documents.
Kaleo Evzio

Kaléo Sued Over Evzio, an Auto-Injector With Pricing Structure Similar to...

Arcane system of pricing and insurance rebates at heart of the suit.
Sanofi

Sanofi Files Suit Against Mylan for Anti-Competitive EpiPen Strategy

More legal troubles for the embattled marketer of EpiPen.

A Deeper Look Into the Racketeering Lawsuit Against Mylan

The suit exposes a convoluted system that works to our detriment.